PRTA Q1 2023 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q1 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+88.1% YoY

Gross Profit

-$43M-1963.4% margin

Operating Income

-$56M-2596.8% margin

Net Income

-$47M-2160.6% margin

EPS (Diluted)

$-0.89

QoQ Revenue Growth

-95.7%

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$48M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$742M

Total Liabilities

$134M

Stockholders' Equity

$607M

Cash & Equivalents

$686M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$1M	+88.1%
Gross Profit	-$43M	-$26M	-63.1%
Operating Income	-$56M	-$38M	-48.4%
Net Income	-$47M	-$36M	-29.1%

Revenue Segments

Collaboration Program, US Rights

$85M49%

US Rights and Global Rights

$85M49%

Collaboration

$2M1%